HIGHLIGHTS
- who: Duneesha De Fonseka from the (UNIVERSITY) have published the article: Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma, in the Journal: (JOURNAL)
- what: This study investigates the prognostic role of the predominant inflammatory cell type within routinely collected diagnostic samples.
SUMMARY
Malignant pleural mesothelioma (MPM) is an aggressive cancer of the pleura with a median survival of 9-14 months from diagnosis. Blood inflammatory markers, e_g total leucocyte count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio and C-reactive protein (CRP) have been . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.